Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05981300 · ClinicalTrials.gov registry record

GpCRC Pediatric Gastroparesis Registry 2

A clinical trial of Gastroparesis and Gastroparesis-like Syndrome, sponsored by Johns Hopkins Bloomberg School of Public Health.

Recruiting
Registry status
216
Enrollment target
6
Study locations

NCT05981300 is a study of Gastroparesis and Gastroparesis-like Syndrome that is actively recruiting participants, run by Johns Hopkins Bloomberg School of Public Health. The registered enrollment target is 216 participants, below the 297-participant average among 44 other Gastroparesis trials with a reported enrollment target (27% lower). The trial reports 6 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05981300, a study of Gastroparesis and Gastroparesis-like Syndrome, is actively recruiting participants, sponsored by Johns Hopkins Bloomberg School of Public Health.

RECRUITING
Registry status
216 participants
Enrollment target
6
Study locations

Study Summary

The objective of the Pediatric Gastroparesis Registry 2 is to create a national prospective registry of children, adolescents, and young adults with gastroparesis and gastroparesis-like syndrome (symptoms of gastroparesis but normal gastric emptying).

Study Locations (6)

Massachusetts

  • Massachusetts General Hospital - Boston
  • Boston Children's Hospital - Boston

Texas

  • Texas Tech University Health Science Center - El Paso
  • Baylor College of Medicine/Texas Children's Hospital - Houston

Ohio

  • Nationwide Children's Hospital - Columbus

Wisconsin

  • Medical College of Wisconsin - Milwaukee

Trial Details

FieldValue
Enrollment Target 216 participants
Start Date 2024-12-18
Est. Completion 2027-06-30

What the Registry Record Tells You About NCT05981300

The ClinicalTrials.gov registry entry for NCT05981300 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 216 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 297-participant average among 44 other Gastroparesis trials with a reported enrollment target (27% lower). The listed sponsor is Johns Hopkins Bloomberg School of Public Health, which has 187 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Gastroparesis appearing as the primary indexed condition, and to 0 interventions.

NCT05981300 reports 6 study locations spanning 4 distinct geographic areas - top geographies include Massachusetts, Texas, Ohio.

Frequently Asked Questions

What is clinical trial NCT05981300 about?

NCT05981300 is a clinical study titled "GpCRC Pediatric Gastroparesis Registry 2". The objective of the Pediatric Gastroparesis Registry 2 is to create a national prospective registry of children, adolescents, and young adults with gastroparesis and gastroparesis-like syndrome (symptoms of gastroparesis but normal gastric emptying).

What is the current status of trial NCT05981300?

This trial is currently recruiting. The enrollment target is 216 participants. The study started on 2024-12-18. Estimated completion is 2027-06-30.

What conditions does trial NCT05981300 study?

This clinical trial studies the following conditions: Gastroparesis, Gastroparesis-like Syndrome.

Who is sponsoring clinical trial NCT05981300?

This trial is sponsored by Johns Hopkins Bloomberg School of Public Health, which has 187 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05981300 being conducted?

This trial has 6 study locations across Massachusetts, Ohio, Texas, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Gastroparesis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.